9823 Capital »

Biogen Idec shares owned by 9823 Capital

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by 9823 Capital from 13F filings

Historical chart of 9823 Capital investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by 9823 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by 9823 Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $539k 2.5k 216.06

More positions owned by 9823 Capital

Apple (AAPL)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
SPDR S&P 500 ETF TR Tr Unit (SPY)
Ishares Tr Ultra Short Dur (ICSH)
T Rowe Price Etf Ultra Shrt Trm (TBUX)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Invesco Actively Managed Exc Ultra Shrt Dur (GSY)
Two Rds Shared Tr Anfield Unvl Etf (AFIF)
Invesco Actively Managed Exc Var Rate Invt (VRIG)
Angel Oak Funds Trust Income Etf (CARY)
Capital Grp Fixed Incm Etf T Us Multi-sector (CGMS)
Comfort Systems USA (FIX)
Targa Res Corp (TRGP)

View all positions for 9823 Capital

Top funds holding Biogen Idec

FMR
BlackRock
PRIMECAP Management Company
Vanguard Capital Management
State Street Corporation
Vanguard Portfolio Management
Geode Capital Management
Wellington Management Company
Norges Bank Investment Management
Morgan Stanley
AQR Capital Management
Jpmorgan Chase & Co
Invesco
Susquehanna International
UBS Group

View all funds holding Biogen Idec